ES2061730T3 - Nuevos anticuerpos. - Google Patents

Nuevos anticuerpos.

Info

Publication number
ES2061730T3
ES2061730T3 ES88810897T ES88810897T ES2061730T3 ES 2061730 T3 ES2061730 T3 ES 2061730T3 ES 88810897 T ES88810897 T ES 88810897T ES 88810897 T ES88810897 T ES 88810897T ES 2061730 T3 ES2061730 T3 ES 2061730T3
Authority
ES
Spain
Prior art keywords
antibodies
cancer
therapy
derivatives
cea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88810897T
Other languages
English (en)
Inventor
Franz Dr Buchegger
Jean-Pierre Prof Dr Mach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Application granted granted Critical
Publication of ES2061730T3 publication Critical patent/ES2061730T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS ANTICUERPOS MONOCLONALES CON ALTA ESPECIFICIDAD Y AFINIDAD CON EL ANTIGENO CANCERINOEMBRIONICO HUMANO (CEA), SUS DERIVADOS, PROCESOS PARA LA PREPARACION DE ESTOS ANTICUERPOS Y SUS DERIVADOS, LINEAS DE CELULA HIBRIDONA QUE SEGREGAN LOS ANTICUERPOS, Y PROCESOS PARA LA PREPARACION DE DICHAS LINEAS DE CELULA. LOS ANTICUERPOS MONOCLONALES DE LA INVENCION Y SUS DERIVADOS SON UTILES EN EL DIAGNOSTICO Y TERAPIUA DE CANCER Y OBDERVACION PERIODICA DE PACIENTES CON CANCER PARA ENFERMEDAD RECURRENTE O RESPUESTA A LA TERAPIA. OBJETOS DE ENSAYO Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN DICHOS ANTICUERPOS ANTI - CEA MONOCLONALES A LOS QUE TAMBIEN SE REFIERE LA INVENCION.
ES88810897T 1988-01-05 1988-12-28 Nuevos anticuerpos. Expired - Lifetime ES2061730T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800078A GB8800078D0 (en) 1988-01-05 1988-01-05 Novel antibodies

Publications (1)

Publication Number Publication Date
ES2061730T3 true ES2061730T3 (es) 1994-12-16

Family

ID=10629465

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88810897T Expired - Lifetime ES2061730T3 (es) 1988-01-05 1988-12-28 Nuevos anticuerpos.

Country Status (12)

Country Link
US (1) US5047507A (es)
EP (1) EP0323805B1 (es)
JP (1) JPH025893A (es)
AT (1) ATE101202T1 (es)
AU (1) AU619232B2 (es)
CA (1) CA1315219C (es)
DE (1) DE3887675T2 (es)
DK (1) DK172440B1 (es)
ES (1) ES2061730T3 (es)
GB (1) GB8800078D0 (es)
IE (1) IE62439B1 (es)
PT (1) PT89385B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122006000007I2 (de) * 1987-12-31 2008-03-27 Tanox Inc -tragenden b-lymphocyten befinden.
GB8800077D0 (en) * 1988-01-05 1988-02-10 Ciba Geigy Ag Novel chimeric antibodies
US5843708A (en) * 1988-01-05 1998-12-01 Ciba-Geigy Corporation Chimeric antibodies
JPH03206886A (ja) * 1989-11-13 1991-09-10 Green Cross Corp:The ヒト腫瘍細胞抗原に対し特異性を持つマウス―ヒトキメラａ１０抗体
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
EP0672253A4 (en) * 1992-01-29 1995-12-06 Sci Clone Inc ANTIGEN (SK1) ASSOCIATED WITH CARCINOMA AND MONOCLONAL ANTIBODIES DIRECTED AGAINST SK1, PROCESSES FOR THE PRODUCTION THEREOF AND APPLICATIONS.
PT584368E (pt) * 1992-02-14 2002-10-31 Suntory Ltd Utilizacao e processo para a producao de um inibidor de metasteses e um inibidor de adesao celular contendo respectivamente um anticorpo
WO1993018139A1 (en) * 1992-03-10 1993-09-16 La Jolla Cancer Research Foundation Recombinant calf intestinal alkaline phosphatase
US5502037A (en) * 1993-07-09 1996-03-26 Neuromed Technologies, Inc. Pro-cytotoxic drug conjugates for anticancer therapy
US5874540A (en) * 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
WO1996017252A1 (en) * 1994-11-28 1996-06-06 Abbott Laboratories Stabilized aqueous steroid immunoassay standards
US5648268A (en) * 1994-12-06 1997-07-15 Ibm Corporation Radionuclide exchange detection of ultra trace ionic impurities in water
US6207805B1 (en) 1997-07-18 2001-03-27 University Of Iowa Research Foundation Prostate cell surface antigen-specific antibodies
US6828157B1 (en) * 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6774209B1 (en) * 2000-04-03 2004-08-10 Dyax Corp. Binding peptides for carcinoembryonic antigen (CEA)
US20020139628A1 (en) * 2001-03-30 2002-10-03 Wen-Chen Chang Retractable handle assembly
WO2004000915A2 (en) * 2002-06-24 2003-12-31 Tufts University Silk biomaterials and methods of use thereof
EP1572131B1 (en) 2002-10-08 2016-07-06 Immunomedics, Inc. Antibody therapy
US7842780B2 (en) 2003-01-07 2010-11-30 Trustees Of Tufts College Silk fibroin materials and use thereof
EP3231846A1 (en) 2003-04-10 2017-10-18 Tufts University Concentrated aqueous silk fibroin solution and use thereof
WO2005000483A1 (en) * 2003-06-06 2005-01-06 Tufts University Method for forming inorganic coatings
JP2006214765A (ja) * 2005-02-01 2006-08-17 Bml Inc ヒトＡｐｏＡ−Ｖ蛋白質に対する抗体、及び、当該抗体を用いたヒトＡｐｏＡ−Ｖ蛋白質定量測定系
JP2010522583A (ja) 2007-02-27 2010-07-08 トラスティーズ オブ タフツ カレッジ 組織工学的に作製された絹製臓器
EA019118B1 (ru) 2007-05-29 2014-01-30 Трастиз Оф Тафтс Колледж Способ желатинизации фиброина шелка и регулирования времени желатинизации, способ инкапсуляции по меньшей мере одного компонента в фиброин шелка (варианты)
WO2009100280A2 (en) * 2008-02-07 2009-08-13 Trustees Of Tufts College 3-dimensional silk hydroxyapatite compositions
WO2009140588A1 (en) * 2008-05-15 2009-11-19 Trustees Of Tufts College Silk polymer-based adenosine release: therapeutic potential for epilepsy
US8501172B2 (en) * 2008-09-26 2013-08-06 Trustees Of Tufts College pH-induced silk gels and uses thereof
MX2011003618A (es) 2008-10-09 2011-06-16 Tufts College Peliculas de seda modificadas que contienen glicerol.
WO2011008842A2 (en) 2009-07-14 2011-01-20 Trustees Of Tufts College Electrospun silk material systems for wound healing
JP2013506058A (ja) 2009-09-28 2013-02-21 タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ 延伸したシルクｅｇｅｌ繊維およびその製造方法
IN2012DN02358A (es) 2009-09-29 2015-08-21 Tufts College
US9603971B2 (en) 2010-03-05 2017-03-28 Trustees Of Tufts College Silk-based ionomeric compositions
JP6081358B2 (ja) 2010-09-01 2017-02-15 トラスティーズ・オブ・タフツ・カレッジＴｒｕｓｔｅｅｓ Ｏｆ Ｔｕｆｔｓ Ｃｏｌｌｅｇｅ 絹フィブロインおよびポリエチレングリコールをベースとする生体材料
EP4218891A1 (en) 2010-10-19 2023-08-02 Trustees Of Tufts College Silk fibroin-based microneedles and methods of making the same
EP2652498B1 (en) 2010-12-16 2018-04-18 F.Hoffmann-La Roche Ag Diagnosis and treatments relating to th2 inhibition
US10335519B2 (en) 2011-04-20 2019-07-02 Trustees Of Tufts College Dynamic silk coatings for implantable devices
ES2856873T3 (es) 2012-02-06 2021-09-28 Childrens Medical Center Biomaterial multicapa para la regeneración de tejidos y la cicatrización de las heridas
ES2738310T3 (es) 2012-10-12 2020-01-21 Medimmune Ltd Pirrolobenzodiazepinas y conjugados de las mismas
CA2905181C (en) 2013-03-13 2020-06-02 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
US10188746B2 (en) 2014-09-10 2019-01-29 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
WO2018069289A1 (en) 2016-10-11 2018-04-19 Medimmune Limited Antibody-drug conjugates with immune-mediated therapy agents
SG11202010469QA (en) 2018-05-23 2020-11-27 Adc Therapeutics Sa Molecular adjuvant
US20230372528A1 (en) 2020-10-16 2023-11-23 University Of Georgia Research Foundation, Inc. Glycoconjugates
GB202102396D0 (en) 2021-02-19 2021-04-07 Adc Therapeutics Sa Molecular adjuvant
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗ｃｅａ抗体
DE3485733D1 (de) * 1983-01-21 1992-06-25 Frederick James Primus Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.
DE3531301A1 (de) * 1985-09-02 1987-03-05 Behringwerke Ag Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
DK2289D0 (da) 1989-01-04
EP0323805A2 (en) 1989-07-12
DE3887675D1 (de) 1994-03-17
EP0323805A3 (en) 1990-04-25
DE3887675T2 (de) 1994-06-30
CA1315219C (en) 1993-03-30
PT89385B (pt) 1993-09-30
AU619232B2 (en) 1992-01-23
DK172440B1 (da) 1998-07-27
GB8800078D0 (en) 1988-02-10
DK2289A (da) 1989-07-06
IE890018L (en) 1989-07-05
ATE101202T1 (de) 1994-02-15
US5047507A (en) 1991-09-10
JPH025893A (ja) 1990-01-10
PT89385A (pt) 1990-02-08
IE62439B1 (en) 1995-02-08
AU2739188A (en) 1989-07-06
EP0323805B1 (en) 1994-02-02

Similar Documents

Publication Publication Date Title
DK2289D0 (da) Monoklonale antistoffer samt deres fremstilling og anvendelse
ES2053810T3 (es) Nuevos anticuerpos quimericos.
ES8505482A1 (es) Un procedimiento para preparar un producto que contiene un anticuerpo monoclonal y un radionuclido metalico
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
ES2131038T3 (es) Procedimiento inmunologico para detectar anticuerpos dirigidos contra la transglutaminasa tisular (ttg), utilizacion de la ttg para fines de diagnostico y de control de terapia y agente farmaceutico oral que contiene la ttg.
SE7512192L (sv) Cancerantigen, cancerterapi och cancerdiagnostikum
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
ES2128362T3 (es) Fragmentos de proteinas de prion.
HUP9903951A2 (hu) Az anti-Fcalfa receptor ellenanyagokat tartalmazó terápiás multispecifikus vegyületek
ES502644A0 (es) Procedimiento de obtencion de nuevos derivados de la vin- blastina
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR9609003A (pt) "reagente para preparação de um radiofarmacêutico kit para preparação de um radiofarmacêutico, composto de hidrazona estável"
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
MX9202851A (es) Derivados de fosfato de los glucosidos de 4-desmetilepipodofilotoxina y composicion farmaceutica que los contiene.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE69315213D1 (de) Photoaktivierung von proteinen zu konjugationszwecken
ES2058908T3 (es) Procedimiento para la separacion y purificacion de sialil-transferasas.
BR0113213A (pt) Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo
ATE244299T1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
ES2133285T3 (es) Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
DK1021534T3 (da) Hepatitis C-receptorprotein CD81
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 323805

Country of ref document: ES